Inventor
IBRAHIM PRABHA
US37 patents
⚠️ This page may combine multiple inventors who share the name “IBRAHIM PRABHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CV THERAPEUTICS INC
20 patentsUS6977300B2Dec 20, 2005
A2B adenosine receptor antagonists
CV THERAPEUTICS INC69 citations98
US6825349B2Nov 30, 2004
A2B adenosine receptor antagonists
CV THERAPEUTICS INC95 citations98
US7317017B2Jan 8, 2008
A2B adenosine receptor antagonists
CV THERAPEUTICS INC22 citations92
US7304070B2Dec 4, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC23 citations92
US6946449B2Sep 20, 2005
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC26 citations92
US6900219B2May 31, 2005
ABCA-1 elevating compounds
CV THERAPEUTICS INC23 citations90
US7105665B2Sep 12, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC12 citations84
US7713946B2May 11, 2010
Partial and full agonists A1 adenosine receptors
CV THERAPEUTICS INC12 citations83
US7144871B2Dec 5, 2006
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC5 citations73
US6930111B2Aug 16, 2005
Substituted heterocyclic compounds
CV THERAPEUTICS INC11 citations73
US7109330B2Sep 19, 2006
Purine inhibitors of cyclin dependent kinase 2 and IκB-α
CV THERAPEUTICS INC6 citations70
US7157440B2Jan 2, 2007
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC5 citations63
US7262198B2Aug 28, 2007
Substituted heterocyclic compounds
CV THERAPEUTICS INC1 citations61
US6849632B2Feb 1, 2005
Heteroaryl alkyl piperazine derivatives
CV THERAPEUTICS INC5 citations60
US7696181B2Apr 13, 2010
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC1 citations51
US7452889B2Nov 18, 2008
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations50
US7115610B2Oct 3, 2006
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations46
US7056924B2Jun 6, 2006
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations41
US7026321B2Apr 11, 2006
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations41
US7001909B2Feb 21, 2006
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations41
AFFERENT PHARMACEUTICALS INC
7 patentsUS10822311B2Nov 3, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC3 citations71
US10662162B2May 26, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC2 citations71
US11230533B2Jan 25, 2022
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC0 citations62
US10676444B2Jun 9, 2020
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC1 citations62
US11591315B2Feb 28, 2023
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
US11230532B2Jan 25, 2022
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC0 citations60
US10988460B2Apr 27, 2021
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
PLEXXIKON INC
3 patentsUS7504509B2Mar 17, 2009
Compounds and methods for development of Ret modulators
PLEXXIKON INC153 citations98
US10227357B2Mar 12, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC7 citations84
US10160755B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC15 citations81